Home/Filings/4/0000899243-18-016975
4//SEC Filing

Ross Leonard S 4

Accession 0000899243-18-016975

CIK 0001314102other

Filed

Jun 17, 8:00 PM ET

Accepted

Jun 18, 4:05 PM ET

Size

8.1 KB

Accession

0000899243-18-016975

Insider Transaction Report

Form 4
Period: 2018-06-14
Ross Leonard S
Corporate Controller
Transactions
  • Award

    Stock Option (right to buy)

    2018-06-14+85,10085,100 total
    Exercise: $2.04Exp: 2028-06-14Common Stock (85,100 underlying)
  • Award

    Restricted Stock Units

    2018-06-14+21,30021,300 total
    Common Stock (21,300 underlying)
Footnotes (3)
  • [F1]Each restricted stock unit represents a contingent right to receive one share of the Company's common stock.
  • [F2]The restricted stock units will vest in three equal annual installments beginning June 14, 2019. Vested shares will be delivered to the reporting person within 30 days following each respective vesting date.
  • [F3]The option to purchase will vest and become exercisable in three equal annual installments beginning June 14, 2019.

Issuer

EyePoint Pharmaceuticals, Inc.

CIK 0001314102

Entity typeother

Related Parties

1
  • filerCIK 0001458753

Filing Metadata

Form type
4
Filed
Jun 17, 8:00 PM ET
Accepted
Jun 18, 4:05 PM ET
Size
8.1 KB